Open AccessSurrogate Indicators of Overall Survival in Advanced Hepatocellular Carcinoma
Author(s) -
Hao-Tian Liu
Publication year - 2022
Publication title -
eurasian journal of medicine and oncology
Language(s) - English
Resource type - Journals
eISSN - 2587-2400
pISSN - 2587-196X
DOI - 10.14744/ejmo.2021.21883
Subject(s) - lenvatinib , sorafenib , medicine , sunitinib , clinical endpoint , oncology , hepatocellular carcinoma , erlotinib , bevacizumab , clinical trial , nintedanib , pazopanib , everolimus , pharmacology , cancer , chemotherapy , idiopathic pulmonary fibrosis , lung , epidermal growth factor receptor